Health Trials

Ambulatory Electrocardiographic Monitoring for the Detection of High-Degree Atrio-Ventricular Block in Patients With New-onset PeRsistent LEft Bundle Branch Block After Transcatheter Aortic Valve Implantation. The "MARE" Study

ConditionsAortic Valve DiseaseConduction Disturbances
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorCentre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

About this trial

The purpose of this study is to determine the incidence and predictors of high degree or complete atrioventricular block (AVB) (paroxysmal or persistent) in patients with new-onset persistent left bundle branch block (NOP-LBBB) following transcatheter aortic valve implantation (TAVI) and to evaluate the usefulness of the Reveal LINQ® insertable Cardiac Monitor (ICM) (Medtronic, Inc., Minneapolis, USA) for the detection of significant arrhythmias in patients with NOP-LBBB following TAVI.

Eligibility criteria

Qualifiers

None

Disqualifiers

Failure to provide informed consent

Baseline pacemaker/defibrillator or pacemaker/defibrillator implanted during the hospitalization period following the TAVI procedure

Pre-existing complete LBBB

Patients with a life-expectancy of less than 2 years

Trial design

Treatments tested in this trial

  • Implantable loop recorders system Reveal ICM LINQ®,

Treatment groups

80 Participants
are divided into 1 treatment group

Locations

1
IUCPQG1V 4G5, QuébecQuebec, Canada

Sponsors and collaborators

Centre de Recherche de l'Institut Universitaire de Cardiologie et de Pneumologie de Quebec

Lead sponsor

Source ClinicalTrials.gov